EMERGENCY:Serious fall injury or swallowing emergency —call040-46324365immediately — 24 hours, 7 days— 24/7
Progressive Supranuclear Palsy (PSP): If It Was Called Parkinson's Disease But Isn't Getting Better — Read This
PSP is almost always misdiagnosed as Parkinson's Disease sometimes for years. Expert PSP diagnosis and specialist care at KIMS Neuroscience, Hyderabad. If Parkinson's medication isn't working and falls are early and severe, seek a second opinion.
PSP · Steele-Richardson-Olszewski Syndrome · Atypical Parkinsonism
Neurodegenerative Disorders · Atypical Parkinsonism · Tauopathies
Movement Disorders · Neurology · Neuropsychology
Falls prevention · Physiotherapy · Speech therapy · Levodopa (limited benefit) · Palliative care
Progressive Supranuclear Palsy is a rare, progressive tauopathy caused by the abnormal accumulation of 4-repeat tau protein in brainstem and basal ganglia neurons. It causes early, severe backwards falls (from year one), difficulty moving the eyes up and down (vertical gaze palsy), axial rigidity, dysarthria, and frontal-executive cognitive changes. PSP is almost universally misdiagnosed as Parkinson's Disease in its early stages, primarily because levodopa provides minimal benefit in PSP. The hummingbird sign on midline sagittal MRI (midbrain atrophy with preserved pons) is its diagnostic imaging hallmark.
- What it is
- Rare tauopathy causing early severe falls (backwards), vertical gaze palsy, axial rigidity, and dysarthria. Regularly misdiagnosed as Parkinson's Disease. Progresses faster than PD.
- Most important warning sign
- Severe falls — particularly backwards — in the first year of disease. This is highly unusual in Parkinson's Disease and is the most important clinical signal for PSP.
- Levodopa response
- Minimal or none — a patient diagnosed with Parkinson's whose medication has never meaningfully helped should be reassessed for PSP.
- Eye movement finding
- Vertical gaze palsy (difficulty looking up and down) — the hallmark diagnostic sign. Found on specialist neurological examination. Not always obvious to family but specifically tested by KIMS neurologist.
- MRI hallmark
- 'Hummingbird sign' — midbrain atrophy visible on midline sagittal MRI. Specific for PSP. Requires specialist interpretation — may be missed on standard radiology report.
- Most urgent intervention
- Falls prevention — from the time of diagnosis. Specific PSP physiotherapy (not standard PD physiotherapy) · home safety assessment · weighted walker · possibly a helmet.
- Contact KIMS
- 040-44885000 · Second opinions accepted · No referral required
| Fact | Details |
|---|---|
| Classification | Atypical parkinsonism · 4-repeat tauopathy · Brainstem and basal ganglia |
| Most important warning sign | Early severe backwards falls in the first year — highly unusual in Parkinson's Disease |
| Levodopa response | Minimal or none — reassess any 'Parkinson's' that never responded to medication |
| Eye sign | Vertical gaze palsy — hallmark sign, tested on specialist examination |
| MRI hallmark | 'Hummingbird sign' — midbrain atrophy with preserved pons on sagittal MRI |
| Most urgent intervention | Falls prevention from diagnosis · PSP-specific physiotherapy · home safety assessment |
| Contact | 040-44885000 · Second opinions accepted · No referral required |
About This Condition
What Is Progressive Supranuclear Palsy?
Progressive Supranuclear Palsy — PSP is a rare, progressive brain disorder that affects movement, balance, eye movements, speech, and thinking. At first glance, it looks very much like Parkinson's Disease. It causes stiffness, slowness, and difficulty walking. It is more common in older adults. It even shows some response initially to Parkinson's medications.
But PSP is not Parkinson's Disease. It is a fundamentally different condition, caused by a different pathological process, affecting different brain regions, progressing faster, responding poorly to levodopa, and producing one group of symptoms that Parkinson's Disease almost never causes: severe early falls, usually backwards, from the first year of the disease.
PSP belongs to a group called the atypical Parkinsonian syndromes conditions that share some features with Parkinson's but are distinct diseases. It is also classified as a tauopathy, because the defining feature at the cellular level is the abnormal accumulation of tau protein the same protein involved in Alzheimer's Disease and some forms of Frontotemporal Dementia in specific regions of the brainstem and basal ganglia.
PSP typically begins in a person's mid- to late-60s, and most people develop severe disability within three to five years of symptom onset. It is rare affecting approximately 6–10 people per 100,000 but its impact on families is profound. And in India, PSP has been actively studied since 1974, with over 80 research publications from Indian centres and a pan-India PSP registry now underway reflecting its genuine clinical importance in the region.
The most important message on this page is simple: if someone has been diagnosed with Parkinson's Disease, their Parkinson's medications are not providing meaningful relief, and they are falling particularly backwards in the first year or two of the disease, a specialist reassessment for PSP is essential. The wrong diagnosis means the wrong management, a missed window for appropriate support planning, and lost time in getting the specific interventions PSP actually requires.
At KIMS Neuroscience, Hyderabad, our specialist neurologists are experienced in distinguishing PSP from Parkinson's Disease and the other atypical Parkinsonian syndromes, using both clinical assessment and the specific MRI findings that support the diagnosis.
Book a Consultation
Speak directly with our specialist team. No referral required. Monday to Saturday.
040-44885000International enquiries: info@kimsneurosciences.comWhat Are the Symptoms of Progressive Supranuclear Palsy?
PSP affects several systems simultaneously movement, eye control, speech, swallowing, and thinking and this combination is both its diagnostic signature and the source of its progressive disability.
Early Falls — The Most Important Warning Sign
The earliest and most distinctive feature of PSP is falls and not just any falls. These are falls that happen with little warning, often backwards, from an early stage. A person with PSP may fall backwards getting out of a chair, standing up from the toilet, or simply walking. The falls happen because the postural reflexes the automatic adjustments the brain makes to keep us upright are severely impaired from the start.
This pattern of early, frequent backward falls appearing in the first year of symptoms is highly unusual in Parkinson's Disease, where balance problems typically develop years into the disease. When a family reports that a relative “keeps falling backwards” and this started early, PSP must be considered.
Difficulty Moving the Eyes — The Hallmark Diagnostic Sign
The defining clinical feature of PSP the one that most often confirms the diagnosis is difficulty moving the eyes, particularly up and down. This is called vertical gaze palsy, and it is specific to PSP.
In practical terms, this means:
• The person finds it hard to look down they may trip on steps because they cannot look downwards effectively to see where they are stepping
• Reading becomes difficult they cannot track down a page or follow a line of text
• They may appear to be staring reduced blinking and difficulty with downward gaze gives the face a fixed, wide-eyed expression sometimes called the “surprised look”
• They may spill food or drinks because they cannot look down at a plate or cup effectively
Early in the disease, only one direction of gaze is affected usually downward gaze first. Both directions are typically affected as the disease progresses. In the earliest stages, the gaze palsy may be subtle and require a specialist's examination to detect it is not always immediately apparent to families.
Stiffness and Slowness — The Parkinson's-like Features
PSP causes significant axial rigidity stiffness predominantly in the neck, trunk, and upper body rather than in the limbs, as is more typical in Parkinson's Disease. This gives PSP patients a characteristic upright, stiff posture tilted slightly backwards rather than the stooped, bent-forward posture more common in Parkinson's.
Movements are slow, initiation of movement is impaired, and the face may be relatively expressionless. These features do look like Parkinson's Disease on first encounter which is exactly why PSP is so consistently misdiagnosed.
Speech and Swallowing Changes
Speech in PSP becomes progressively slower, lower in volume, and less clearly articulated sometimes described as slurred or strangled. The voice may lose its variation in pitch and become monotone. These changes reflect the involvement of the bulbar muscles controlled by the brainstem, and they can appear relatively early in PSP.
Swallowing difficulties follow liquids and thin foods are the first challenge. The risk of aspiration food or liquid entering the airway increases as the disease progresses, making aspiration pneumonia the most common cause of death in PSP.
Thinking and Behaviour Changes
PSP affects the frontal lobes, producing cognitive and behavioural changes similar to those seen in Frontotemporal Dementia:
• Slowed thinking and difficulty processing information quickly
• Apathy, a marked loss of motivation and initiative that families often mistake for depression
• Impaired executive function difficulty planning, organising, and adapting to new situations
• Emotional lability laughing or crying more easily than the situation warrants
Memory is relatively preserved in early PSP which is one way it differs from Alzheimer's Disease.
What Causes Progressive Supranuclear Palsy?
Progressive Supranuclear Palsy (PSP) is caused by the abnormal accumulation of tau protein, a protein that is normally present and functional in brain cells inside specific groups of neurons. When tau becomes abnormally phosphorylated (chemically modified), it clumps together inside the cell, disrupting its function and eventually killing it.
The brain regions most affected in PSP include the subthalamic nucleus, substantia nigra, globus pallidus, and several brainstem structures particularly those controlling eye movements and postural reflexes. This anatomical pattern explains the distinctive combination of symptoms PSP produces. PSP is closely related to other tau protein diseases including Alzheimer's Disease, Frontotemporal Dementia, and Corticobasal Degeneration. Together these are grouped as tauopathies.
Why does tau accumulate in PSP?
The direct cause of abnormal tau accumulation in PSP is not fully understood. Most cases are sporadic they occur without a family history and without an identified genetic cause.
In rare cases, mutations in the MAPT gene which encodes the tau protein are associated with PSP or PSP-like disease. Certain genetic variants (particularly the H1 haplotype of the MAPT gene) are consistently found at higher frequency in people with PSP compared to the general population, but these are risk factors rather than direct causes.
Environmental factors including exposure to certain toxins and chemical compounds have been investigated but not confirmed as causes. PSP is not strongly inherited in most cases.
Risk Factors
• Age — PSP is rare before 60 and most commonly affects those in their mid-60s to 70s.
• Male sex — PSP is slightly more common in men than women.
• Genetic variants in the MAPT gene, a risk factor, not a direct cause.
• No established modifiable environmental risk factors.
Diagnosis at KIMS
How Is Progressive Supranuclear Palsy Diagnosed at KIMS?
Diagnosing PSP accurately is one of the most clinically demanding assessments in movement disorder neurology. In the early stages, PSP can be misdiagnosed as Parkinson's Disease or Alzheimer's Disease due to overlap in symptoms. There is no single blood test that confirms PSP. The diagnosis is built from the clinical picture, the pattern of symptom progression, and targeted investigations.
Step 1: A detailed clinical history focused on the PSP pattern
The specialist will ask specifically about when and how falls began particularly whether falls were early, frequent, and predominantly backwards; eye movement difficulties whether the person has trouble looking down, reading, or has developed a staring expression; the response to levodopa in PSP, improvement from Parkinson's medication is either minimal or absent. A person who received a Parkinson's diagnosis but has never meaningfully responded to levodopa is a strong candidate for reassessment; the speed of progression PSP progresses more rapidly than Parkinson's Disease; and voice and speech changes the pattern in PSP is specific.
Step 2: A specialist neurological examination
The neurologist performs a detailed assessment of eye movements specifically testing the range of voluntary vertical gaze, checking whether the limitation is in the voluntary movement (which is affected early) or in the reflex movement (which is preserved longer in PSP). A test called the Doll's Eye manoeuvre gently moving the head while the patient fixates on a target can reveal preserved reflex eye movements even when voluntary gaze is limited, helping confirm the supranuclear origin of the palsy. Postural stability is formally tested. The pull test the neurologist stands behind the patient and gives a gentle backward pull on the shoulders reveals severely impaired postural reflexes in PSP. A patient with early PSP may fall backwards with a single pull, whereas a patient with Parkinson's typically catches themselves.
Step 3: Brain MRI — the hummingbird sign
MRI of the brain in PSP typically shows atrophy of the midbrain the portion of the brainstem just above the pons. When the midbrain shrinks while the pons remains relatively preserved, the profile of the brainstem on a midline sagittal MRI view takes on a characteristic appearance often described as the "hummingbird sign" or "penguin sign." This finding is one of the most useful imaging markers for PSP and helps distinguish it from Parkinson's Disease, where midbrain atrophy is not a feature. A specialist neuroradiologist's interpretation of the MRI with PSP-specific measurements the midbrain-to-pons ratio is important. A general radiology report may miss the subtle early changes.
Step 4: FDG-PET scan (selected cases)
In diagnostically uncertain cases particularly where the MRI changes are subtle or early an FDG-PET scan showing reduced metabolic activity in the frontal lobes and basal ganglia can support the PSP diagnosis.
Step 5: Neuropsychological assessment
A detailed cognitive assessment characterises the frontal-executive impairment typical of PSP, distinguishes it from the memory-dominated decline of Alzheimer's, and documents baseline function for monitoring.
Distinguishing PSP from Parkinson's Disease, A Summary for Families
| Feature | PSP | Parkinson's Disease |
|---|---|---|
| Early falls | Yes, backwards, within first year | No, typically years into disease |
| Eye movement problems | Yes, vertical gaze palsy | Rare |
| Levodopa response | Minimal or none | Good initial response |
| Posture | Upright, sometimes tilted back | Stooped, bent forward |
| MRI midbrain | Atrophy, hummingbird sign | Normal |
| Progression speed | Faster | Slower |
Treatment
How Is PSP Treated at KIMS?
There is no cure for PSP and no treatment that slows or reverses its progression. There's currently no cure for PSP and no way to slow it down but several treatments can help manage symptoms and improve quality of life. Management at KIMS Neuroscience is multidisciplinary and focused on two core goals: reducing the risk of the most dangerous complications particularly falls and aspiration and maintaining the best possible quality of life for as long as possible.
Medications — limited benefit, but worth trying
Levodopa, the main Parkinson's medication is usually tried in PSP, but the response is typically modest at best. Some patients experience a modest and temporary improvement in stiffness and slowness. It is worth a trial but should not be relied upon as the primary management strategy. Amantadine an antiviral medication that also has some effects on dopamine and glutamate is sometimes helpful for PSP-related motor symptoms and can be tried alongside levodopa. Antidepressants particularly SSRIs are used for the emotional lability and apathy that PSP causes. They can meaningfully reduce the distress caused by uncontrollable laughing or crying. Botulinum toxin injections are useful for specific focal symptoms eyelid spasms that keep the eyes closed (blepharospasm) can be treated with botulinum toxin injected into the muscles around the eye, and dystonic neck postures (the neck pulled backwards or sideways) can also be partially treated this way.
Falls prevention — the single most important safety priority
Falls in PSP are severe, frequent, and from an early stage. They are the primary source of serious injury head injuries, hip fractures, and wrist fractures and a major cause of hospitalisation. Falls prevention requires a coordinated effort: Physiotherapy specific balance training, gait modification, and advice on how to move safely. PSP physiotherapy is different from Parkinson's physiotherapy, because the postural instability mechanism is different. Our physiotherapist at KIMS is experienced in PSP-specific techniques.
Mobility aids and home safety
A walking frame with a weighted front (to resist the backwards tipping tendency) is often more helpful than a standard walking stick. A wheelchair may be needed earlier than families expect typically within 3–4 years. Home safety assessment our occupational therapist assesses the home for fall hazards and recommends specific modifications: removing loose rugs, installing grab rails, considering a shower chair, repositioning furniture to allow safe walking routes. Helmet use for patients with very frequent falls, a lightweight protective helmet can significantly reduce the severity of head injuries.
Eye care
The eye movement problems in PSP can cause significant practical difficulties difficulty reading, navigating stairs, and seeing food on a plate. An ophthalmologist or optometrist experienced with PSP can advise on: Prism glasses to help compensate for limited downward gaze. Eyelid crutches simple spectacle attachments to prop up the eyelids in patients with blepharospasm. Large-print books and screen magnifiers. Adjusting the environment placing food and objects in the centre of the visual field rather than requiring the person to look down.
Speech and swallowing management
Speech therapy in PSP serves the same dual function as in ALS supporting communication as speech deteriorates, and monitoring swallowing safety. Regular swallowing assessments are essential, with dietary texture modification and positioning advice to reduce aspiration risk. The speech therapist introduces communication strategies early while speech is still present and advises on AAC tools as speech declines. A PEG feeding tube may be considered in the later stages of PSP when swallowing is severely impaired the same considerations apply as in ALS: timing it before the patient becomes too weak to tolerate the procedure safely.
Palliative care — from diagnosis
The same principle that applies in ALS applies in PSP: palliative care is not end-of-life care, it is quality-of-life care. The prognosis in PSP is shorter than many families initially understand, and early conversations about future care preferences advance care planning give patients the opportunity to express their wishes while they are able to do so fully. Our palliative care team at KIMS is involved from the time of diagnosis, not as a signal that hope is lost, but as part of the best comprehensive care available.
When Should You Seek a Specialist Assessment for PSP?
Come to KIMS Neuroscience, Hyderabad for a specialist second opinion if the symptoms suggest Progressive Supranuclear Palsy rather than typical Parkinson's Disease. Early specialist assessment helps ensure the right diagnosis, the right management plan, and timely support for both patients and families.
You can come to KIMS without a formal referral. A second opinion is a completely reasonable request. A correct diagnosis even if the underlying prognosis is unchanged means the right management, the right support planning, and the right honest conversations about what lies ahead. Families who pursue a correct PSP diagnosis consistently report that knowing even when the news is not what they hoped is better than being managed for the wrong condition.
A family member has been diagnosed with Parkinson's Disease but the levodopa medication has never significantly improved their symptoms
Falls have been occurring since the early stages of the illness particularly backwards falls rather than only years in
The person has developed difficulty looking up or down, or has acquired a fixed, staring expression
Speech has changed in a way that sounds strained, slow, or monotone earlier than would be expected in typical Parkinson's
Swallowing difficulties appeared earlier than the movement problems, or alongside them
The disease is progressing faster than the diagnosing neurologist expected for Parkinson's
What to Expect — Living with PSP
PSP progresses faster than Parkinson's Disease. Most people with PSP eventually need a wheelchair and may need part- or full-time care as early as three to four years into living with PSP. People with PSP typically die six to nine years after their diagnosis though this varies. The most common cause of death is aspiration pneumonia, caused by progressive swallowing difficulties.
Knowing this honestly and planning for it is the most important thing a family can do after a PSP diagnosis. The window of meaningful independence, with the right support, can be extended. Falls can be reduced, swallowing can be managed safely, communication can be maintained for longer, and quality of life can be preserved better than most families expect when they first receive the diagnosis.
For families in Hyderabad and Telangana: the period immediately after a PSP diagnosis is the most important time to access specialist care. The physiotherapy should start immediately. The swallowing assessment should begin. The home safety review should happen. Waiting until things deteriorate means managing a crisis rather than preventing it.
The KIMS Neuroscience team is available to support every stage of this journey from the initial diagnostic assessment through to the advanced stages of the disease and the care of the whole family.
Related Conditions
Progressive Supranuclear Palsy belongs to a broader family of neurodegenerative and movement-related disorders:
FAQs
Frequently Asked Questions
Has a family member been diagnosed with Parkinson's Disease — but the medications aren't working and the falls are severe?
PSP is regularly misdiagnosed as Parkinson's Disease in its early stages. At KIMS Neuroscience, Secunderabad, our specialist neurologists have the expertise and the diagnostic tools including PSP-specific MRI analysis and detailed eye movement assessment to make the correct diagnosis. The right diagnosis means the right management. You do not need a referral letter.
info@kimsneurosciences.com